Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth...

Anna Chiara Piscaglia, Thomas Shupe, Bryon Petersen, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)


Subsequent to an initiating event, tumor promotion requires sustained cell proliferation to allow for progressive accumulation of pro-oncogenic mutations. The unique characteristics of stem cells would seem to implicate these cells as particularly suitable targets for carcinogens. Several lines of evidence suggest that tumors harbor a small population of cancer stem cells (CSC) which both give rise to the bulk of the tumor and are tumorigenic in experimental models. Mounting evidence suggests that these cells are responsible for re-growth of a tumor following unsuccessful treatment and for the establishment of metastases. The concept of CSC has been demonstrated in several human cancers including leukemia, breast, prostate, lung, and brain tumors. Taken together, the properties of CSC suggest that they are appropriate targets for cancer therapies. Such treatments would require a deep understanding of the CSC origin, molecular profile, and interaction with the local microenvironment. This report will summarize what is currently known regarding CSC, with particular emphasis on hepatic cancers, the cellular origin of liver tumors, and the role of liver stem cells and their niche in hepatocarcinogenesis.
Lingua originaleEnglish
pagine (da-a)582-590
Numero di pagine9
RivistaCurrent Cancer Drug Targets
Stato di pubblicazionePubblicato - 2007


  • liver
  • stem cells


Entra nei temi di ricerca di 'Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth...'. Insieme formano una fingerprint unica.

Cita questo